Clarify Health, a San Francisco company that sells referral intelligence, quality measurement and network performance software to health systems, said on June 4, 2026 that it had completed its acquisition of Loyal Health Holdings, the parent of patient activation platform Loyal. Terms of the transaction were not disclosed.
Loyal now operates as a wholly owned subsidiary of Clarify. Todd Gottula, Clarify's CEO and co-founder, leads the combined company. Nanette Oddo, who ran Loyal, was described in the announcement as its former CEO.
The two companies said existing customers of both businesses would keep receiving the same products, services and support. Orrick, Herrington & Sutcliffe advised Clarify on the legal side, Goodwin Procter acted as legal counsel to Loyal, and OM Partners was Loyal's financial advisor.
What Loyal built
Loyal was founded in 2015 and is headquartered in Atlanta, according to LevinPro Healthcare. It sells a platform built specifically for health systems that covers provider data management, care search, real-time scheduling, reputation management, AI-powered chat and customer relationship management. The company describes itself as one of the first to apply AI to digital patient engagement.
Its Care Activation Platform manages more than 80,000 provider and location profiles and handles millions of patient searches and real-time scheduling transactions each year, according to the release. The product uses clinically validated taxonomies and connects natively to electronic health record systems. Oddo said close to 500 hospitals rely on the platform.
The customer base has grown quickly. When Loyal announced its Series B in July 2024, it reported 38 health system customers. Less than two years later, the acquisition announcement put the number of hospitals relying on the platform at close to 500, a count of individual hospitals rather than health systems.
“Loyal has built a platform that close to 500 hospitals rely on to connect patients with the care they need”
Why Clarify is buying
Clarify's main product is Meridian, an analytics platform that maps where patients are referred, measures how much business leaks out of a health system's network and points to areas for growth. What Clarify did not have was a way to act on that analysis by contacting patients and getting them booked. Loyal fills that gap with targeted outreach, digital engagement and live scheduling.
The companies said the combined platform would track the whole chain in one view, from identifying a referral through the patient's appointment and the care that follows. Clarify's machine learning models for quality, cost and network performance will run alongside Loyal's AI scheduling, chat and propensity models.
Gottula framed the deal as a split of roles between the two products. "Clarify provides the intelligence. Loyal provides the activation. Together, we're giving health systems the ability to run the full loop from referral to measured outcome," he said.
Will Reed, a general partner at Spark Capital who sits on Clarify's board, said the industry was moving toward AI-enabled outcomes delivery and that Clarify, with Loyal's activation tools, would be the platform for it.
The problem both companies point to
The announcement cited industry research estimating that 30% to 50% of referrals never turn into a completed visit, which it said costs health systems 10% to 30% of potential revenue. With median hospital operating margins near 1%, the companies argued that even small amounts of referral leakage can decide whether a hospital can keep investing.
They also described the issue as one of quality and access, not just money. In their view the root cause is structural: the data about where a patient should go sits in one system, and the tools that move the patient there sit in another. Many health systems, they said, have tried to fix each part separately.
The founders and the funding
Loyal was founded by Chad Mallory, who served as chairman and CEO until July 2024. In October 2020 it announced a $12.5 million Series A led by Concord Health Partners, a healthcare-focused investment firm, to expand its consumer experience platform for hospitals and health systems.
In July 2024 Loyal closed a $33.5 million Series B with participation from Concord Health Partners and several strategic investors that were not named. At the same time Mallory stepped down to become a senior advisor, and Saurabh Sinha, founder and chairman of Emids Technologies, became chairman of Loyal's board. The two reported rounds add up to $46 million.
Neither company disclosed Loyal's headcount or revenue, or what Clarify paid. LevinPro Healthcare counted the deal as the 101st eHealth acquisition of 2026 in its database and the 15th in the patient engagement segment, after 301 eHealth and 44 patient engagement deals in 2025.
